Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-30

Clinical Trial Update: AZD5672 Bioavailability Study in Healthy Male and Female Subjects [Phase 1]

View source ↗

Summary

AZD5672 completed a Phase 1 bioavailability study in healthy male and female subjects. The trial lists rheumatoid arthritis as the condition associated with the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZD5672 (AZD5672)

Snippet

Sponsor: AstraZeneca | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED